Product Information
IMATINIB MESYLATE 100 MG TAB is a generic product labeled by Apotex Corp., priced at $0.6632 per EA under NDC 60505290009. Its NADAC has been published 462 times since Sep 21, 2016.
Strength
100 mg/1
Manufacturer
Apotex Corp.NDC
60505290009
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA079179On Market Since
8/5/2016
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 100 MG TAB has been published 462 times since Sep 21, 2016, and over the history we have for it it has declined 99.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6632 per EA |
|---|---|
| All-time high | $74.5901 (Nov 16, 2016) |
| All-time low | $0.3890 (May 22, 2024) |
| 52-week high | $0.9761 |
| 52-week low | $0.6632 |
| Median price | $2.0686 |
| Average price | $13.3997 |
| Largest weekly change | -82.3% (Oct 17, 2018) |
| Weeks tracked | 462 |
| Tracking since | Sep 21, 2016 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 100 MG TAB, manufactured by Apotex Corp., is $0.6632 per EA (NDC 60505290009), effective Jun 24, 2026.
How has the price of IMATINIB MESYLATE 100 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 100 MG TAB has declined 99.1%. It has been tracked across 462 weekly CMS publications since Sep 21, 2016.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 100 MG TAB?
Since Sep 21, 2016, the NADAC for IMATINIB MESYLATE 100 MG TAB has ranged from a low of $0.3890 (May 22, 2024) to a high of $74.5901 (Nov 16, 2016), with a median of $2.0686 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 100 MG TAB?
6 NADAC-published products share the same active ingredient, strength, and dosage form as IMATINIB MESYLATE 100 MG TAB, but none are currently priced below it.
Who manufactures IMATINIB MESYLATE 100 MG TAB?
IMATINIB MESYLATE 100 MG TAB (NDC 60505290009) is labeled by Apotex Corp., and CMS classifies it as a generic product.
Related Drugs
Same classification